Security Snapshot

Savara Inc - Common Stock, par value $0.001 per share (SVRA) Institutional Ownership

CUSIP: 805111101

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

184

Shares (Excl. Options)

212,257,668

Price

$5.46

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+10,582,442
Value change
+$54,962,865
Number of holders
184
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
210,922,101
SEC-reported price per share
$5.23
Insider filing price
$5.23
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SVRA - Savara Inc - Common Stock, par value $0.001 per share is tracked under CUSIP 805111101.
  • 184 institutions reported positions in Q1 2026.
  • 11 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 148 to 184 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,213,175,994 to $1,158,874,829.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 184 institutions filings for Q1 2026.

Open SEC evidence

Security key

805111101

Latest holder period

Q1 2026

13F holders

184

13D/G owners

11

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
11
Security
SVRA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Growth Equity Opportunities 17, LLC 12% $87,362,412 24,471,264 Growth Equity Opportunities 17, LLC 12 Nov 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% +37% $123,617,225 +$48,545,450 20,881,288 +65% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
Bain Capital Life Sciences Fund II, L.P. 10% $55,969,975 17,600,621 Bain Capital Life Sciences Fund II, L.P. 25 Mar 2025
Farallon Capital Partners, L.P. 6.9% -31% $90,445,500 -$19,831,599 15,000,000 -18% Dapice Joshua J. 31 Dec 2025
Flynn James E 6.7% $48,441,330 13,569,000 Deerfield Mgmt, L.P. 30 Oct 2025
TCG Crossover GP I, LLC 6.1% $73,184,254 12,362,205 TCG Crossover GP I, LLC 31 Dec 2025
BlackRock, Inc. 5.4% +12% $66,069,364 +$15,933,163 10,957,322 +32% BlackRock, Inc. 31 Dec 2025
Frazier Life Sciences Public Fund, L.P. 4.1% +5% $49,390,844 +$9,458,692 8,343,048 +24% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
Nantahala Capital Management, LLC 3.6% -29% $43,481,115 -$8,469,105 7,344,783 -16% Nantahala Capital Management, LLC 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 3.2% $17,431,660 5,481,654 Wellington Management Group LLP 31 Dec 2024
Vestal Point Capital, LP 2.3% -67% $14,333,550 -$24,133,200 4,015,000 -63% Vestal Point Capital, LP 30 Sep 2025

As of 31 Mar 2026, 184 institutional investors reported holding 212,257,668 shares of Savara Inc - Common Stock, par value $0.001 per share (SVRA). This represents 101% of the company’s total 210,922,101 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
85%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 12% 24,471,264 0% 7.6% $133,613,101
Bain Capital Life Sciences Investors, LLC 8.3% 17,600,621 0% 8.7% $96,099,391
Venrock Adviser, LLC 6.5% 13,740,375 0% 2.8% $75,022,448
DEERFIELD MANAGEMENT COMPANY, L.P. 6.4% 13,569,000 0% 0.87% $74,086,740
TCG Crossover Management, LLC 5.9% 12,362,205 0% 1.9% $67,497,639
BlackRock, Inc. 5.4% 11,291,185 +1.7% 0% $61,649,869
Frazier Life Sciences Management, L.P. 4.6% 9,720,852 -1.4% 1.4% $53,075,852
Polar Capital Holdings Plc 4.5% 9,541,786 +15% 0.23% $52,098,152
VANGUARD CAPITAL MANAGEMENT LLC 3.7% 7,783,913 0% 0% $42,500,165
Nantahala Capital Management, LLC 3.5% 7,344,783 0% 2.5% $40,102,515
STATE STREET CORP 3.2% 6,707,684 +55% 0% $36,623,955
RTW INVESTMENTS, LP 2.8% 5,952,380 0% 0.32% $32,499,995
MARSHALL WACE, LLP 2.1% 4,514,348 -1% 0.03% $24,648,341
Woodline Partners LP 2% 4,245,119 +0.01% 0.09% $23,178,350
GEODE CAPITAL MANAGEMENT, LLC 1.7% 3,594,480 +5.2% 0% $19,630,308
Spruce Street Capital LP 1.6% 3,383,175 +40% 4.4% $18,472,136
EMERALD ADVISERS, LLC 1.6% 3,371,285 -3.6% 0.58% $18,407,216
Rosalind Advisors, Inc. 1.5% 3,203,721 -5.9% 7.2% $17,492,317
WELLINGTON MANAGEMENT GROUP LLP 1.3% 2,710,723 +1.3% 0% $14,800,547
Vestal Point Capital, LP 1.2% 2,600,052 +62% 0.4% $14,196,284
Affinity Asset Advisors, LLC 1.2% 2,512,153 -10% 0.8% $13,716,355
EMERALD MUTUAL FUND ADVISERS TRUST 1.1% 2,368,669 -1.2% 0.63% $12,932,933
Pictet Asset Management Holding SA 1.1% 2,275,381 0.01% $12,423,580
D. E. Shaw & Co., Inc. 1% 2,111,882 +27% 0.01% $11,530,876
NAN FUNG TRINITY (HK) LTD 0.87% 1,842,350 +9.1% 1.1% $10,059,231

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
38
Latest
Q1 2026
Rows shown
1-25 of 38
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 212,257,668 $1,158,874,829 +$54,962,865 $5.46 184
2025 Q4 201,186,328 $1,213,175,994 +$226,717,931 $6.03 148
2025 Q3 163,027,204 $581,865,188 -$17,744,664 $3.57 124
2025 Q2 167,625,869 $382,185,936 +$4,604,999 $2.28 121
2025 Q1 165,084,968 $457,300,361 +$4,913,528 $2.77 133
2024 Q4 162,865,251 $500,000,306 -$4,524,160 $3.07 134
2024 Q3 160,489,937 $680,419,874 +$47,632,176 $4.24 124
2024 Q2 148,167,816 $597,127,886 +$107,030,245 $4.03 130
2024 Q1 121,071,712 $602,921,495 +$11,975,850 $4.98 119
2023 Q4 118,973,088 $559,183,072 +$9,052,732 $4.70 97
2023 Q3 116,727,664 $441,241,214 +$105,054,525 $3.78 83
2023 Q2 89,090,177 $284,756,437 +$19,803,798 $3.20 76
2023 Q1 83,504,156 $162,832,384 +$6,962,703 $1.95 67
2022 Q4 79,984,853 $123,981,605 +$92,945 $1.55 52
2022 Q3 79,924,185 $123,886,636 +$4,248,900 $1.55 47
2022 Q2 77,190,826 $117,329,451 +$2,431,393 $1.52 47
2022 Q1 75,835,578 $99,344,996 +$1,530,761 $1.31 45
2021 Q4 74,670,485 $92,591,002 -$976,827 $1.24 45
2021 Q3 75,014,959 $103,530,069 -$1,889,497 $1.38 54
2021 Q2 76,209,813 $129,561,285 +$1,307,097 $1.70 69
2021 Q1 75,191,392 $156,437,847 +$111,831,290 $2.08 77
2020 Q4 21,657,964 $24,908,582 -$596,543 $1.15 61
2020 Q3 17,084,936 $18,623,392 -$4,005,800 $1.09 62
2020 Q2 19,585,868 $48,753,921 +$1,741,034 $2.49 68
2020 Q1 18,855,821 $39,855,026 +$5,880,157 $2.12 66
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .